Source: Health Canada shortage reports · Updated Jul 23, 2026
Some Lisdexamfetamine products are in shortage in Canada (3 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
A stimulant medication used to treat attention deficit hyperactivity disorder (ADHD).
Products affected
3 / 18
In shortage since
Jun 16, 2026
Est. full return
Aug 7, 2026
Reports on file
27
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-LISDEXAMFETAMINE CAPSULES
20MG · CAPSULE · APOTEX INC
DIN 02546655 · since Jun 23, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-LISDEXAMFETAMINE CAPSULES
40MG · CAPSULE · APOTEX INC
DIN 02546671 · since Jun 16, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-LISDEXAMFETAMINE CAPSULES
10MG · CAPSULE · APOTEX INC
DIN 02546647 · since Jun 16, 2026, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
10MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546248 · ended Jun 1, 2026 · Delay in shipping of the drug.
Resolved
PRO-LISDEXAMFETAMINE
10MG · CAPSULE · PRO DOC LIMITEE
DIN 02547031 · ended Mar 24, 2026 · Disruption of the manufacture of the drug.
DIN 02533375 · ended Sep 25, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
40MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546272 · ended Apr 28, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
60MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546299 · ended Jan 13, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
40MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546272 · ended Jan 13, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
50MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546280 · ended Jan 13, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
30MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546264 · ended Jan 13, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
10MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546248 · ended Oct 21, 2024 · Requirements related to complying with good manufacturing practices.
Showing 12 of 27 reports. All reports are on file with Health Canada.
What's happening
Lisdexamfetamine is currently affected by 3 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Lisdexamfetamine is classified under “PSYCHOSTIMULANTS AND NOOTROPICS” (ATC N06BA).
Recent changes
Jul 23, 2026
Estimated end date pushed back : Jul 24, 2026 → Aug 7, 2026
Jul 23, 2026
Estimated end date pushed back : Jul 24, 2026 → Aug 7, 2026
Common questions
What is Lisdexamfetamine used for?
A stimulant medication used to treat attention deficit hyperactivity disorder (ADHD).
When will Lisdexamfetamine be back in stock in Canada?
The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Lisdexamfetamine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.